PRESS RELEASE SUCCESS OF THE CAPITAL INCREASE BY PRIVATE PLACEMENT FOR AN AMOUNT OF 15 MILLION EUROS Paris, April 24, 2023, 8am CET AB Science S.A. , announces today the success of its capital. | April 24, 2023
In a first of its kind comparative study, Mindpeak's CE-marked HER2 AI for breast cancer diagnosis was compared to three other commercial AIs (e.g. Visiopharm). Mindpeak's AI showed the highest accuracy
CD40HVac, a therapeutic vaccine candidate in immuno-oncology targeting dendritic cells LinKinVax, a clinical-stage biotechnology company specialized in innovative protein-based vaccines, and Gustave
NEWYORK, Dec. 1, 2022 /PRNewswire/ France's Gustave Roussy Institute, Europe's leading cancer center and ranked third in the world according to Newsweek Magazine, has chosen to partner with